Gene locus FDP1 of the dystonic Mount-Reback type of autosomal-dominant paroxysmal choreoathetosis

Neurology

Volumn 49, Issue 5, 1997, Pages 1252-1256

  Hofele, K ^b   Benecke, R ^b   Auburger, Georg ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; DNA; ION CHANNEL;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHOREOATHETOSIS; CHROMOSOME 2Q; CLINICAL ARTICLE; DYSTONIA; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HUMAN; MALE; MIGRAINE; PEDIGREE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; ADOLESCENT; ADULT; ATHETOSIS; CHILD; CHOREA; CHROMOSOME 2; CHROMOSOME MAP; DOMINANT GENE; FAMILY HEALTH; GENETICS; MUTATION; ONSET AGE; PHENOTYPE;

ADOLESCENT; ADULT; AGE OF ONSET; ATHETOSIS; CHILD; CHOREA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; FAMILY HEALTH; GENES, DOMINANT; HUMANS; MIGRAINE DISORDERS; MUTATION; PEDIGREE; PHENOTYPE;

EID: 0031280420     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.49.5.1252     Document Type: Article

References (24)

1. Mount LA, Reback S. Familial paroxysmal choreoathetosis: preliminary report of a hitherto undescribed clinical syndrome. Arch Neurol 1940;44:841-846.
2. Richards RN, Barnett HJM. Paroxysmal dystonic choreoathetosis: a family study and review of the literature. Neurology 1968;18:461-469.
3. Przuntek H, Monninger P. Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type. J Neurol 1983;230: 163-169.
4. Schloesser DT, Ward TN, Williamson PD. Familial paroxysmal dystonic choreoathetosis revisited. Mov Disord 1996;11: 317-320.
5. Tibbles JAR, Barnes SE. Paroxysmal dystonic choreoathetosis of Mount and Reback. Pediatrics 1980;65:149-151.
6. Lance JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 1977; 2:285-293.
7. Fahn S. The paroxysmal dyskinesias. In: Marsden CD, Fahn S, eds. Movement disorders. Oxford: Butterworth-Heinemann 1994:310-345.
8. Smith LA, Heersema PH. Periodic dystonia. Mayo Clin Proc 1941;16:842-846.
9. Jung SS, Chen KM, Brody JA. Paroxysmal choreoathetosis: report of Chinese cases. Neurology 1973;23:749-755.
10. Kertesz A. Paroxyxsmal kinesigenic choreoathetosis: an entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 1967;17:680-690.
11. Auburger G, Ratzlaff T, Lunkes A, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996;31:90-94.
12. Fouad GT, Servidei S, Durcan S, Bertini E, Ptácek LJ. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 1996;59:135-139.
13. Fink JK, Rainier S, Wilkowski J, et al. Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q. Am J Hum Genet 1996;59:140-145.
14. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Ehrlich HA. Analysis of enzymatically amplified beta-globin and HLA-DQalpha DNA with allele specific oligonucleotide probe. Nature 1986;324:163-166.
15. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984;81:3443-3446.
16. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/ myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nature Genet 1994; 8:136-140.
17. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet 1995;11:201-203.
18. Rees MI, Andrew M, Jaward S, Owen MJ. Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor. Hum Mol Gen 1994;3:2175-2179.
19. Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257:797-800.
20. George AL, Crackover MA, Abdalla JA, Hudson AJ, Ebers GC. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenital). Nature Genet 1993;3:305-310.
21. Ptácek LJ, George AL, Griggs RC, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-1027.
22. Rojas CV, Wang J, Schwartz LS, Hoffman EP, Powell BR, Brown RH Jr. A Met to Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalemic periodic paralysis. Nature 1991;354:387-389.
23. Ptácek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-868.
24. Gillard EF, Otsu K, Fuji J, et al. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991; 11:751-755.